华宝恒生港股通创新药精选ETF

(520880)公募权益被动型股票型指数型
各季度资产配置
季报日期 净资总值(亿元) 净资净值(亿元) 股票 债券 现金 其他
市值(亿元) 占净值比例(%) 占总值比例(%) 市值(亿元) 占净值比例(%) 占总值比例(%) 市值(亿元) 占净值比例(%) 占总值比例(%) 市值(亿元) 占净值比例(%) 占总值比例(%)
2026-06-3023.8622.8422.7595.12%95.33%0.000.00%0.00%0.190.83%0.80%0.924.05%3.87%
2026-03-3123.5423.0422.9597.44%97.49%0.000.00%0.00%0.512.21%2.16%0.080.35%0.35%
2025-12-3121.1221.0020.9198.98%98.98%0.000.00%0.00%0.211.02%1.02%0.000.00%0.00%
2025-09-3018.2618.0617.9598.24%98.26%0.000.00%0.00%0.150.81%0.80%0.170.95%0.94%
2025-06-305.144.350.7918.08%15.32%0.000.00%0.00%4.3581.92%84.68%0.000.00%0.00%